ONCT - Oncternal Therapeutics' (ONCT) CEO Jim Breitmeyer on Q2 2020 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT)
Q2 2020 Earnings Conference Call
August 6, 2020 5:00 PM ET
Company Participants
Richard Vincent – Chief Financial Officer
Jim Breitmeyer – President & Chief Executive Officer
Frank Hsu – Chief Medical Officer
Conference Call Participants
Robert Burns – H.C. Wainwright
Presentation
Operator
Greetings, and welcome to Oncternal's Q2 Financial Results Call. [Operator Instructions] Please note that this conference call is being recorded.
I will now turn the conference over to our host, Richard Vincent, CFO of Oncternal Therapeutics. Thank you. You may begin.
Richard Vincent
Thank you, operator. Good afternoon,